Universitas Kristen Indonesia
40
DAFTAR PUSTAKA

1. Febriani A, Furqon A. Metastasis Kanker Paru. Jurnal Respirasi.
2020;4(3):94.
2. Global Burden of Cancer at the World Health Organization. 2021;
3. Robot RY, Durry MF, Kairupan CF. Morfologi, Patogenesis, dan
Imunoterapi Kanker Paru Tipe Adenokarsinoma. Medical Scope
Journal. 2021;3(1):74.
4. Sugiharto S, Simanjuntak RAP, Larissa O. Kanker Paru, Faktor Risiko
Dan Pencegahannya. Prosiding SENAPENMAS. 2021;613.
5. Wheless L, Brashears J, Alberg AJ. Epidemiology of lung cancer. Lung
Cancer Imaging. 2013;1–15.
6. Paulsen F, Waschke J. Sobotta Clinical Atlas of Human Anatomy, one
volume, English. Elsevier Health Sciences; 2019.
7. Mescher AL. Junqueira’s basic histology: text and atlas. 2013;
8. Hall JE, Hall ME. Guyton and Hall textbook of medical physiology e-
Book. Elsevier Health Sciences; 2020.
9. Sherwood L. Human physiology. BROOKS; 2019.
10. Sharma R. Mapping of global, regional and national incidence,
mortality and mortality-to-incidence ratio of lung cancer in 2020 and
2050. International Journal of Clinical Oncology. 2022;27(4):665–75.
11. Bade BC, Cruz CSD. Lung cancer 2020: epidemiology, etiology, and
prevention. Clinics in chest medicine. 2020;41(1):1–24.
12. Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH,
et al. Cancer treatment and survivorship statistics. CA: a cancer journal
for clinicians. 2016;66(4):271–89.
13. Suraya A, Nowak D, Sulistomo AW, Icksan AG, Berger U, Syahruddin
E, et al. Excess risk of lung cancer among agriculture and construction
workers in Indonesia. Annals of Global Health. 2021;87(1).

Universitas Kristen Indonesia
41
14. Thandra KC, Barsouk A, Saginala K, Aluru JS, Barsouk A.
Epidemiology of lung cancer. Contemporary Oncology/Współczesna
Onkologia. 2021;25(1):45–52.
15. Fiorelli A, D’Andrilli A, Carlucci A, Vicidomini G, Loizzi D, Ardò NP,
et al. Prognostic factors of lung cancer in lymphoma survivors (the
LuCiLyS study). Translational Lung Cancer Research. 2020;9(1):90.
16. Zhang Y, Luo G, Etxeberria J, Hao Y. Global patterns and trends in
lung cancer incidence: a population-based study. Journal of Thoracic
Oncology. 2021;16(6):933–44.
17. Pavlisko EN, Roggli VL. Lung cancer: Clinical findings, pathology,
and exposure assessment. Occupational Cancers. 2020;205–26.
18. Azhdarpoor A, Hoseini M, Shahsavani S, Shamsedini N, Gharehchahi
E. Assessment of excess lifetime cancer risk and risk of lung cancer
due to exposure to radon in a middle eastern city in Iran. Radiation
Medicine and Protection. 2021;2(03):112–6.
19. Agarwal P, Chaudhari S, Jagati A, Rathod S, Neazee S. Clinical
spectrum of pregnancy related dermatoses in a tertiary care hospital in
western India. Natl J Community Med. 2020;11:450–5.
20. Kushwah AS, Banerjee M. Genetics Of Glutathione S-transferases and
Complex Diseases. Igor Azevedo Silva, Glutathione S-Transferases:
Structure, Functions and Clinical Aspects, Nova Science Publishers
Inc New York USA. 2020;1–38.
21. North CM, Christiani DC. Women and lung cancer: what is new? In
Elsevier; 2013. p. 87–94.
22. Shen H, Zhu M, Wang C. Precision oncology of lung cancer: genetic
and genomic differences in Chinese population. NPJ precision
oncology. 2019;3(1):14.
23. Mithoowani H, Febbraro M. Non-small-cell lung cancer in 2022: A
review for general practitioners in oncology. Current Oncology.
2022;29(3):1828–39.

Universitas Kristen Indonesia
42
24. Kocher F, Hilbe W, Seeber A, Pircher A, Schmid T, Greil R, et al.
Longitudinal analysis of 2293 NSCLC patients: a comprehensive study
from the TYROL registry. Lung Cancer. 2015;87(2):193–200.
25. Gayen S. Malignant pleural effusion: presentation, diagnosis, and
management. The American Journal of Medicine. 2022;
26. Shojaee S, Roy-Chowdhuri S, Safi J, Grosu HB. Cytologic
Investigations for the Diagnosis of Malignant Pleural Effusion in Non–
small Cell Lung Cancer: State-of-the-art Review for Pulmonologists.
Journal of Bronchology & Interventional Pulmonology.
2021;28(4):310–21.
27. Asciak R, Bedawi EO, Bhatnagar R, Clive AO, Hassan M, Lloyd H, et
al. British Thoracic Society Clinical Statement on pleural procedures.
Thorax. 2023;78(Suppl 3):s43–68.
28. Klein-Weigel PF, Elitok S, Ruttloff A, Reinhold S, Nielitz J, Steindl J,
et al. Superior vena cava syndrome. Vasa. 2020;
29. Nooreldeen R, Bach H. Current and future development in lung cancer
diagnosis. International journal of molecular sciences.
2021;22(16):8661.
30. Aljohaney AA. Real time endobronchial ultrasound transbronchial
needle aspiration for the diagnosis of tuberculous intrathoracic
lymphadenopathy: Saudi Arabian Western region experience. Saudi
Medical Journal. 2023;44(2):178.
31. Latimer KM, Mott TF. Lung cancer: diagnosis, treatment principles,
and screening. American family physician. 2015;91(4):250–6.
32. Sager O, Dincoglan F, Demiral S, Gamsiz H, Uysal B, Ozcan F, et al.
Optimal timing of thoracic irradiation for limited stage small cell lung
cancer: Current evidence and future prospects. World Journal of
Clinical Oncology. 2022;13(2):116.
33. Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG.
Introduction to the 2015 World Health Organization classification of

Universitas Kristen Indonesia
43
tumors of the lung, pleura, thymus, and heart. Journal of Thoracic
Oncology. 2015;10(9):1240–2.
34. Pandi A, Mamo G, Getachew D, Lemessa F, Kalappan V,
Dhiravidamani S. A brief review on lung cancer. Int J Pharma Res
Health Sci. 2016;4:907–14.
35. Chang JT, Anic GM, Rostron BL, Tanwar M, Chang CM. Cigarette
smoking reduction and health risks: a systematic review and meta-
analysis. Nicotine and Tobacco Research. 2021;23(4):635–42.
36. US Department of Health and Human Services. The health
consequences of smoking—50 years of progress: a report of the
surgeon general.2014;
37. Shankar A, Dubey A, Saini D, Singh M, Prasad CP, Roy S, et al.
Environmental and occupational determinants of Lung Cancer.
Translational Lung Cancer Research. 2019;8(S1)
38. Ninomiya T, Nogami N, Kozuki T, Harada D, Kubo T, Ohashi K, et al.
Survival of chemo-naïve patients with EGFR mutation-positive
advanced non-small cell lung cancer after treatment with afatinib and
bevacizumab: updates from the Okayama Lung Cancer Study Group
Trial 1404. Japanese journal of clinical oncology. 2021;51(8):1269–76.
39. Cui R, Wei C, Li X, Jiang O. A meta-analysis of adjuvant EGFR-TKIs
for patients with EGFR mutation of resected non-small cell lung
cancer. Medicine. 2022;101(47).
40. PS V, MH G, Krishna KJ, CD S, AL L. Outcomes and Prognostic
Factors of Extensive Stage Small Cell Lung Cancer: A Retrospective
Study. South Asian Journal of Cancer. 2023;
41. Planchard D, Popat S, Kerr K, Novello S, Smit EF, Faivre-Finn C, et
al. Metastatic non-small cell lung cancer: ESMO Clinical Practice
Guidelines for diagnosis, treatment and follow-up. Annals of
oncology: official journal of the European Society for Medical
Oncology. 2018;29: 192–237.
42. Cancer incidence by age. Cancer Research UK. 2015

Universitas Kristen Indonesia
44
43. Aisah SKN, Haryati H, Bakhriansyah M. Profil Penderita Kanker Paru
Primer Di RSUD Ulin Banjarmasin Tahun 2006-2011. Berkala
Kedokteran. 2013;9(2):169–80.
44. Clark SB, Alsubait S. Non Small Cell Lung Cancer. PubMed. Treasure
Island (FL): StatPearls Publishing; 2020.
45. Logawathi, Satthiyabalan A/L Sivabalan. Karakteristik Penderita
Kanker Paru di RSUP Haji Adam Malik Medan Tahun 2016-2018.
2016;